AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.89
+0.11
(+0.80%)
Pre-Market: 08:38
AbCellera Biologics Enterprise Value : 3.794B for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 3.794B |
| October 02, 2026 | 3.781B |
| October 01, 2026 | 3.834B |
| September 30, 2026 | 4.042B |
| September 29, 2026 | 4.112B |
| September 28, 2026 | 3.837B |
| September 25, 2026 | 3.463B |
| September 24, 2026 | 3.447B |
| September 23, 2026 | 3.343B |
| September 22, 2026 | 3.447B |
| September 21, 2026 | 3.450B |
| September 18, 2026 | 3.441B |
| September 17, 2026 | 3.472B |
| September 16, 2026 | 3.147B |
| September 15, 2026 | 3.067B |
| September 14, 2026 | 2.994B |
| September 11, 2026 | 2.908B |
| September 10, 2026 | 2.776B |
| September 09, 2026 | 2.957B |
| September 08, 2026 | 3.077B |
| September 04, 2026 | 3.073B |
| September 03, 2026 | 3.116B |
| September 02, 2026 | 3.052B |
| September 01, 2026 | 3.027B |
| August 31, 2026 | 3.089B |
| Date | Value |
|---|---|
| August 28, 2026 | 3.049B |
| August 27, 2026 | 3.371B |
| August 26, 2026 | 3.322B |
| August 25, 2026 | 3.401B |
| August 24, 2026 | 2.822B |
| August 21, 2026 | 3.040B |
| August 20, 2026 | 3.116B |
| August 19, 2026 | 3.251B |
| August 18, 2026 | 2.978B |
| August 17, 2026 | 3.003B |
| August 14, 2026 | 3.058B |
| August 13, 2026 | 2.932B |
| August 12, 2026 | 2.744B |
| August 11, 2026 | 2.562B |
| August 10, 2026 | 2.433B |
| August 07, 2026 | 1.694B |
| August 06, 2026 | 1.572B |
| August 05, 2026 | 1.385B |
| August 04, 2026 | 1.437B |
| August 03, 2026 | 1.357B |
| July 31, 2026 | 1.320B |
| July 30, 2026 | 1.314B |
| July 29, 2026 | 1.222B |
| July 28, 2026 | 1.192B |
| July 27, 2026 | 1.179B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MindWalk Holdings Corp. | 67.07M |
| Repligen Corp. | 10.57B |
| Bio-Techne Corp. | 11.35B |
| Aurinia Pharmaceuticals, Inc. | 1.710B |
| BioLife Solutions, Inc. | 1.821B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -55.43M |
| Revenue (Quarterly) | 4.05M |
| Total Expenses (Quarterly) | 59.48M |
| EPS Diluted (Quarterly) | -0.1814 |
| Gross Profit Margin (Quarterly) | -116.9% |
| Profit Margin (Quarterly) | -1.37K% |
| Earnings Yield | -3.95% |
| Normalized Earnings Yield | -3.967 |